Počet záznamov: 1
heparín
SYS d006493 LBL 00000cx--j22000003--45-- 005 20240119201016.7 100 $a 19990101csloy0103----ba0 152 $b mesh 250 $a heparín $x AA $x AD $x AE $x AG $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $8 slo 300 1-
$a /therapeutic use was HEPARIN, THERAPEUTIC 1965 $8 eng 330 1-
$a A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. $8 eng 450 $a Heparinic Acid $5 e $8 eng 450 $a alpha-Heparin $5 e $8 eng 450 $a kyselina heparínová $5 e $8 slo 450 $a alfa-heparín $5 e $8 slo 550 $3 sllk_un_auth*d000925 $Y Anticoagulants $5 P $a antikoagulanciá 550 $3 sllk_un_auth*d005343 $Y Fibrinolytic Agents $5 P $a fibrinolytiká 686 $a D09.698.373.400 750 $a Heparin $8 eng 801 -0
$a US $b DNLM $c 19990101 801 -2
$a SK $b BA006 $c 20010615 980 $x M
Počet záznamov: 1